The methods for handling missing data in clinical trials influence sample size requirements

This publication has 23 references indexed in Scilit:

• A 5-year randomized controlled, double-blind study of glycosaminoglycan polysulphuric acid complex (Rumalon®) as a structure modifying therapy in osteoarthritis of the hip and knee
  Osteoarthritis and Cartilage, 2000
• Assessing Smallest Detectable Change Over Time in Continuous Structural Outcome Measures: Application to Radiological Change in Knee Osteoarthritis
  Journal of Clinical Epidemiology, 1999
• Is conventional radiography suitable for evaluation of a disease-modifying drug in patients with knee osteoarthritis?
  Osteoarthritis and Cartilage, 1997
• Radiological progression of hip osteoarthritis: definition, risk factors and correlations with clinical status.
  Annals of the Rheumatic Diseases, 1996
• Statistical power, sample size, and their reporting in randomized controlled trials
  Published by American Medical Association (AMA) ,1994
• Radiographic progression of hospital referred osteoarthritis of the hip.
  Annals of the Rheumatic Diseases, 1993
• Binary methods for continuous outcomes: A parametric alternative
  Journal of Clinical Epidemiology, 1991
• The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip
  Arthritis & Rheumatism, 1991
• The Importance of Beta, the Type II Error and Sample Size in the Design and Interpretation of the Randomized Control Trial
  New England Journal of Medicine, 1978
• Radiological Assessment of Osteo-Arthrosis
  Annals of the Rheumatic Diseases, 1957